Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di Milano.

Published on May 4, 2020in Tumori1.707
· DOI :10.1177/0300891620923790
Franco Valenza28
Estimated H-index: 28
 (University of Milan), Gabriele Papagni1
Estimated H-index: 1
 + 14 AuthorsGiovanni Apolone54
Estimated H-index: 54
Sources
Abstract
Background:The rapid spread of coronavirus disease (COVID-19) is affecting many countries. While healthcare systems need to cope with the need to treat a large number of people with different degre...
Figures & Tables
Download
📖 Papers frequently viewed together
202033.75Lancet Oncology
12 Authors (Wenhua Liang, ..., Jianxing He)
1,748 Citations
20202.69BMC Infectious Diseases
7 Authors (Wang Deng, ..., Daoxin Wang)
12 Citations
20218.31Clinical Infectious Diseases
9 Authors (Vera Schwierzeck, ..., Stefanie Kampmeier)
39 Citations
References1
Newest
Jul 20, 2019·European Journal of Cancer7.28
#1Ugo PastorinoH-Index: 25
#1Ugo PastorinoH-Index: 58
Last. Alfonso MarchianòH-Index: 31
view all 10 authors...
Abstract Background The Multicentric Italian Lung Detection (MILD) trial demonstrated that prolonged low-dose computed tomography (LDCT) screening could achieve a 39% reduction in lung cancer (LC) mortality. We have here evaluated the long-term results of annual vs. biennial LDCT and the impact of screening intensity on overall and LC-specific mortality at 10 years. Patients and methods Between 2005 and 2018, the MILD trial prospectively randomised the 2376 screening arm participants to annual (...
22 CitationsSource
1
Cited By17
Newest
Apr 1, 2021·Cancer5.74
#1Alice IndiniH-Index: 10
#2M. Cattaneo (University of Udine)H-Index: 2
Last. Francesco GrossiH-Index: 34
view all 11 authors...
1 CitationsSource
Mar 2, 2021·Cancers6.13
#1Chiara Maura CiniselliH-Index: 13
#2Arianna MicaliH-Index: 1
Last. Mariangela FiginiH-Index: 26
view all 11 authors...
Since the beginning of the COVID-19 outbreak, Cancer Centers adopted specific procedures both to protect patients and to monitor the possible spread of SARS-CoV-2 among healthcare personnel (HCP). In April 2020 at Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, one of the three oncologic hubs in Lombardy where the Health Regional Authorities referred all the cancer patients of the region, we implemented a prospective longitudinal study aimed at monitoring the serological response to SARS...
Source
1 CitationsSource
Mar 1, 2021·European Journal of Cancer Care2.16
#1Valentina Biagioli (Sapienza University of Rome)H-Index: 6
#1Valentina Biagioli (Sapienza University of Rome)H-Index: 1
Last. Rosario CarusoH-Index: 8
view all 5 authors...
2 CitationsSource
Feb 1, 2021·Tumori1.71
#1Celeste Cagnazzo (UNITO: University of Turin)H-Index: 9
#2Marie Georges Besse
Last. Gualberto GussoniH-Index: 15
view all 13 authors...
The coronavirus disease 2019 (COVID-19) pandemic has stressed the importance of health research as never before. In the specific domain of clinical research, the effort to rapidly find responses to health challenges and therapeutic hypotheses has highlighted the need for efficient, timely, ethically correct research. The guidelines published by the Agenzia Italiana del Farmaco have shown that some useful changes are feasible: simple and rapid methods have been implemented to conduct clinical res...
1 CitationsSource
Jan 26, 2021·Frontiers in Immunology5.08
#1Wilma Barcellini (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 31
#2Juri Alessandro Giannotta (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 7
Last. Bruno Fattizzo (University of Milan)H-Index: 15
view all 3 authors...
During COVID-19 pandemic the care of onco-hematologic and autoimmune patients has raised the question whether they are at higher risk of infection and/or worse outcome. Here we describe the clinical course of COVID-19 pneumonia in patients with autoimmune cytopenias (AIC) regularly followed at a reference center in Northern Italy. The study period started from COVID-19 outbreak (Februrary, 22 2020) until the time of writing. Moreover we provide a review of the literature, showing that most cases...
Source
Jan 22, 2021·Supportive Care in Cancer2.63
#1Cengiz Karacin (UHSA: University of Health Sciences Antigua)H-Index: 2
#2Ramazan Acar (UHSA: University of Health Sciences Antigua)H-Index: 3
Last. Mutlu Dogan (UHSA: University of Health Sciences Antigua)
view all 10 authors...
PURPOSE: COVID-19 will continue to disrupt the diagnosis-treatment process of cancer patients. Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital has been considered as a 'non-pandemic' center ('clean') in Ankara, the capital city of Turkey. The other state hospitals that also take care of cancer patients in Ankara were defined as 'pandemic' centers. This study aimed to evaluate hospital admission changes and the precautionary measures in clean and pandemic centers during the pandemic. The effec...
Source
Abstract Study Objective There are growing concerns on the potential risk of COVID-19 transmission during surgery and in particular during minimally invasive procedure, due to the aerosolization of SARS-CoV-2 particles. However, no study demonstrated this hypothesis. Here, we aimed to investigate the presence SARS-CoV-2 through surgical smoke. Design A prospective pilot study. Setting A third-level cancer center in Northern Italy. Patients Overall, 17 patients had laparoscopic approach for the m...
Source
Oct 12, 2020·Tumori1.71
#1Amelia BarcelliniH-Index: 4
#2Andrea Riccardo Filippi (UNIPV: University of Pavia)H-Index: 24
Last. Ester OrlandiH-Index: 22
view all 7 authors...
3 CitationsSource
Oct 12, 2020·Cancers6.13
#1Erica QuaquariniH-Index: 7
#2Giuseppe SaltalamacchiaH-Index: 1
Last. Federico SottotettiH-Index: 10
view all 14 authors...
4 CitationsSource
12